Asset
Zoldonrasib
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06922591 | phase1_2 | recruiting | 2025-05-31 | 2027-06-01 | Tango Therapeutics, Inc. | Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients |
FDA applications (0)
This company has no applications containing this asset.